Education and Training
Determining the Efficacy of Essential Oil Aromatherapy in Children Undergoing Port Access
The purpose of this study is to determine if the use of aromatherapy impacts patient anxiety and pain scores surrounding port access in pediatric oncology patients between the ages of 4 years and 18 years.
Stanford is currently accepting patients for this trial.
Intervention(s):
- other: STILL QuickTAB Medipack blended scent aromatherapy, manufactured by Soothing Scents
Eligibility
Inclusion Criteria:
1. Children between 4 years and 18 years
2. Scheduled for port access with or without lab draw
3. Oncology, neuro-oncology, and stem cell transplant patients
Exclusion Criteria:
1. has asthma, reactive airway disease, or allergies to any of the ingredients we are
using in the aromatherapy study (lavender, bergamot, sweet orange, and ylang ylang)
2. currently uses aromatherapy for port accesses or other painful procedures (does not
apply to patients using aromatherapy, such as peppermint oil, for nausea)
3. has a cognitive impairment that prevents them from being able to provide anxiety or
pain scores
4. does not wish to participate in the study
Ages Eligible for Study
4 Years - 18 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Renee A Nolen, MSN, RN
573-823-8296
I'm interested